Ghorai Atanu, Sarma Asitikantha, Chowdhury Priyanka, Ghosh Utpal
Department of Biochemistry & Biophysics, University of Kalyani, Kalyani, 741235, India.
Present address: Department of Biological Sciences, Tata Institute of Fundamental Research (TIFR), Homi Bhabha Road, Colaba, Mumbai, 400005, India.
Radiat Oncol. 2016 Sep 22;11(1):126. doi: 10.1186/s13014-016-0703-x.
Hadron therapy is an innovative technique where cancer cells are precisely killed leaving surrounding healthy cells least affected by high linear energy transfer (LET) radiation like carbon ion beam. Anti-metastatic effect of carbon ion exposure attracts investigators into the field of hadron biology, although details remain poor. Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors are well-known radiosensitizer and several PARP-1 inhibitors are in clinical trial. Our previous studies showed that PARP-1 depletion makes the cells more radiosensitive towards carbon ion than gamma. The purpose of the present study was to investigate combining effects of PARP-1 inhibition with carbon ion exposure to control metastatic properties in HeLa cells.
Activities of matrix metalloproteinases-2, 9 (MMP-2, MMP-9) were measured using the gelatin zymography after 85 MeV carbon ion exposure or gamma irradiation (0- 4 Gy) to compare metastatic potential between PARP-1 knock down (HsiI) and control cells (H-vector - HeLa transfected with vector without shRNA construct). Expression of MMP-2, MMP-9, tissue inhibitor of MMPs such as TIMP-1, TIMP-2 and TIMP-3 were checked by immunofluorescence and western blot. Cell death by trypan blue, apoptosis and autophagy induction were studied after carbon ion exposure in each cell-type. The data was analyzed using one way ANOVA and 2-tailed paired-samples T-test.
PARP-1 silencing significantly reduced MMP-2 and MMP-9 activities and carbon ion exposure further diminished their activities to less than 3 % of control H-vector. On the contrary, gamma radiation enhanced both MMP-2 and MMP-9 activities in H-vector but not in HsiI cells. The expression of MMP-2 and MMP-9 in H-vector and HsiI showed different pattern after carbon ion exposure. All three TIMPs were increased in HsiI, whereas only TIMP-1 was up-regulated in H-vector after irradiation. Notably, the expressions of all TIMPs were significantly higher in HsiI than H-vector at 4 Gy. Apoptosis was the predominant mode of cell death and no autophagic death was observed.
Our study demonstrates for the first time that PARP-1 inhibition in combination with carbon ion synergistically decreases MMPs activity along with overall increase of TIMPs. These data open up the possibilities of improvement of carbon ion therapy with PARP-1 inhibition to control highly metastatic cancers.
强子疗法是一种创新技术,癌细胞可被精确杀死,而周围健康细胞受高传能线密度(LET)辐射(如碳离子束)的影响最小。碳离子照射的抗转移作用吸引了研究人员进入强子生物学领域,尽管细节仍不清楚。聚(ADP - 核糖)聚合酶 - 1(PARP - 1)抑制剂是众所周知的放射增敏剂,几种PARP - 1抑制剂正在进行临床试验。我们之前的研究表明,PARP - 1缺失使细胞对碳离子的放射敏感性高于γ射线。本研究的目的是探讨PARP - 1抑制与碳离子照射联合对HeLa细胞转移特性的影响。
在85 MeV碳离子照射或γ射线照射(0 - 4 Gy)后,使用明胶酶谱法测量基质金属蛋白酶 - 2、9(MMP - 2、MMP - 9)的活性,以比较PARP - 1敲低(HsiI)细胞和对照细胞(H - 载体 - 转染无shRNA构建体载体的HeLa细胞)之间的转移潜能。通过免疫荧光和蛋白质印迹检查MMP - 2、MMP - 9、MMP组织抑制剂如TIMP - 1、TIMP - 2和TIMP - 3的表达。在每种细胞类型中,碳离子照射后研究台盼蓝染色的细胞死亡、凋亡和自噬诱导情况。数据采用单因素方差分析和双侧配对样本T检验进行分析。
PARP - 1沉默显著降低MMP - 2和MMP - 9的活性,碳离子照射进一步将其活性降低至对照H - 载体的3%以下。相反,γ射线照射增强了H - 载体中MMP - 2和MMP - 9的活性,但在HsiI细胞中未增强。碳离子照射后,H - 载体和HsiI中MMP - 2和MMP - 9的表达呈现不同模式。在HsiI中所有三种TIMP均增加,而照射后H - 载体中仅TIMP - 1上调。值得注意的是,在4 Gy时,HsiI中所有TIMP的表达均显著高于H - 载体。凋亡是细胞死亡的主要方式,未观察到自噬性死亡。
我们的研究首次证明,PARP - 1抑制与碳离子联合可协同降低MMPs活性,同时TIMP总体增加。这些数据为通过PARP - 1抑制改善碳离子疗法以控制高转移性癌症开辟了可能性。